Business
Germany recommends against giving Oxford-AstraZeneca vaccine to over 65s – Sydney Morning Herald
The country’s vaccine committee says there is not enough trial data available for the age group. Australia says it trusts the TGA’s assessment.

The experts endorsed the vaccines rollout for people aged 18 to 64.
The European Unions drug regulator, the European Medicines Agency, will hand down its verdict on the vaccine on Friday.
Australia has rights to 53.8 million doses of the vaccine developed by AstraZeneca and the University of Oxford, representing the bulk of its initial portfolio.
The Australian Therapeutic Goods Administration has also been scrutinising AstraZenecas trial data ahead of an expected decision in February on whether…
-
Noosa News23 hours ago
New South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News17 hours ago
Help to make recycling stick
-
Noosa News15 hours ago
Former Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Business17 hours ago
Alphabet’s stock looks like a brilliant buy right now